Opaleye Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Opaleye Management’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-350,000	Closed	-$21.7M	–	71
2020 Q4	$21.7M	Sell	350,000 -6,000	-2%	-$344K	2.83%	8
2020 Q3	$19.5M	Sell	356,000 -5,600	-2%	-$301K	3.82%	6
2020 Q2	$20.8M	Hold	361,600	–	–	4.2%	4
2020 Q1	$14.5M	Hold	361,600	–	–	3.85%	9
2019 Q4	$13.8M	Buy	361,600 +161,600	+81%	+$2.84M	2.72%	16
2019 Q3	$1.36M	Buy	+200,000	New	+$1.5M	0.49%	41

Other funds holding CCXI

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Opaleye Management's CCXI Position: Q1 2021 in Review

Opaleye Management sold out of ChemoCentryx, Inc. (CCXI) in Q1 2021, closing a stake of 350,000 shares — an estimated $21.7M sold.

Opaleye Management first reported a position in CCXI in Q3 2019 and held it in 6 quarters. The position peaked at $21.7M in Q4 2020. 183 funds tracked by Wall St. Rank hold CCXI as of Q1 2021.

Opaleye Management reported no remaining ChemoCentryx, Inc. position as of Q1 2021 after selling out during the quarter.
Opaleye Management sold 350,000 ChemoCentryx, Inc. shares in Q1 2021, an estimated $21.7M.
Opaleye Management first reported a position in ChemoCentryx, Inc. in Q3 2019 and held it in 6 quarters.
Opaleye Management's ChemoCentryx, Inc. position peaked at $21.7M in Q4 2020.
183 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q1 2021.

Based on Opaleye Management's 13F filing for Q1 2021, filed 18 May 2021.